NCT01480063 An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice Status COMPLETED Phase N/A
NCT01465087 Nanotechnology for Detection of Multiple Sclerosis Compared to Autoimmune and Neurological Diseases by Exhaled Samples Status COMPLETED Phase NA
NCT01464749 Task-oriented Circuit Class Training in Multiple Sclerosis Subjects Status COMPLETED Phase NA
NCT01457924 Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01455220 The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis Status COMPLETED Phase NA
NCT01454791 Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate Status COMPLETED Phase PHASE4
NCT01453764 Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis Status WITHDRAWN Phase NA
NCT01451723 Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II Status TERMINATED Phase PHASE2
NCT01450488 Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01450072 Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE Status COMPLETED Phase NA
NCT01448252 T Cell Vaccination in Patients With Progressive Multiple Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT01442194 Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies Status COMPLETED Phase N/A
NCT01440101 Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) Status COMPLETED Phase PHASE2/PHASE3
NCT01440062 Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS) Status TERMINATED Phase PHASE2
NCT01433250 A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01432704 Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) Status COMPLETED Phase PHASE2/PHASE3